GRI Bio secures U.S. composition of matter patent

GRI Bio (GRI) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 12,528,775, providing robust new intellectual property protection for novel compound compositions central to the Company’s platform of immunomodulators. The newly issued patent includes composition-of-matter claims covering a distinct class of proprietary compounds defined by linked molecular structures that form pyrrolidine, piperidine, or azepane ring systems. These specific molecular configurations represent a key structural advancement and are separate and distinct from patents previously issued to the Company, further strengthening the durability of GRI Bio’s intellectual property estate.